Functionally Important Structurally-Specific Homodimerization of the Glucagon Like Peptide 1 Receptor  by Harikumar, Kaleeckal G.
514a Tuesday, February 28, 2012Explicitly stating all potential states and their potential interactions is not fea-
sible for very large networks. Modelers often deal with this problem by lim-
iting the scope of the network considered, limiting the biochemical resolution
considered, or imposing non-physiological reaction specifications that dramat-
ically reduce the number of states. These simplifications are generally unsat-
isfactory. The cost of these common simplifications on predictive ability is
not well understood. We have rather developed a rule-based approach for ef-
ficiently specifying and simulating reaction networks. This ‘‘rule-based’’ ap-
proach enables simulations of mechanistic models of cell signaling networks
with resolution and scope far larger than traditional modeling methods. We
have built a comprehensive model of IGF1R phosphorylation and SH2/PTB
signaling that can account for over 1014 possible non-isomorphic complexes.
We have also built a model of ErbB family signaling that spans from the four
ErbB receptors through ERK and Akt activation and that can account for over
10150 possible non-isomorphic complexes. We have used these models to in-
vestigate how protein promiscuity may modulate signaling and also to inves-
tigate how feedback loops expand the range of signals a network may
generate. Now that we have demonstrated the ability to develop and simulate
such large models, we turn our attention to how oncogenic mutants disrupt
these signaling networks.
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Recent studies have reached mixed conclusions regarding the lifetime and
fraction of G Protein-Coupled Receptor (GPCR) oligomers in living cells.
Whilst a few, recently published, single-molecule imaging studies suggest
transient association between GPCRs, fluorescence recovery after photo-
bleaching (FRAP) has led to variable conclusions. Two closely related GPCRs,
the b1-adrenergic receptor (B1AR) and b2- adrenergic receptor (B2AR), were
proposed to form transient interactions and stable homomeric complexes, re-
spectively. To obtain a rigorous mechanistic insight into the association of
B1AR and B2AR in the cell membrane, at a level of molecular detail beyond
that currently attainable by experimental techniques, we have calculated the
free energy of association of these receptors using biased molecular dynamics
simulations, in particular, a combination of umbrella sampling and metady-
namics. Representing explicitly solvated (in a palmitoyl-oleoyl-phosphatidyl-
choline (POPC)/10 % cholesterol bilayer) B2AR and B1AR crystal structures
using the MARTINI coarse-grained force field, we studied their homo-
dimerization at symmetric interfaces formed by transmembrane (TM) helices
that have been implicated in GPCR association (i.e., TM1, TM4, and TM4/
5). Reconstruction of the free-energy surfaces as a function of the inter-
protomeric distance demonstrates different relative stability of the B1AR or
B2AR dimers depending on the sequence and/or the different structural fea-
tures at the interface. Specifically, we observe that: a) For both receptors, di-
mers interacting at interfaces defined by TM1 are more stable than TM4 or
TM4/5 dimers; and b) Between the two receptors, the B2AR dimers appear
to be generally - albeit not significantly - more stable than the B1AR dimers.
Our calculations can be generally applied across family A GPCRs, and offer
a novel insight into the mechanism of GPCR dimerization in the cell
membrane.
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The lipid membrane environment has been shown to play a significant role
in the function and organization of G-protein coupled receptors (GPCRs) and
other transmembrane proteins. We now show quantitatively how small se-
quence differences between otherwise highly homologous GPCRs can result
in strikingly different membrane interaction characteristics. This is evidenced
by comparing the membrane interactions of two pairs of functionally related
family A GPCRs - (1) the beta1 and beta2 adrenergic receptors; and, (2) the
kappa- and delta- opioid receptors, embedded in a lipid bilayer composed of
a 16:0-18:1 PC (POPC) /10% Cholesterol mixture. We used the recently de-
scribed 3D Continuum-Molecular dynamics (3D-CTMD) approach (Mondal
et al., BJ (in press)) to quantify the membrane deformation profile and cor-responding energy costs due to the protein/membrane hydrophobic mis-
match. The novel computational method accounts for the irregular
hydrophobic surface of the protein and the hydrophobic mismatch at partic-
ular TMs that is not alleviated by membrane deformations. A description of
the irregular membrane-protein interface from MD simulations of protomeric
receptors with the coarse-grained Martini force field provided the informa-
tion on the membrane-protein boundary needed to quantify with 3D-
CTMD the energetics of membrane deformation for each system. The spe-
cific residues involved in unfavorable polar-to-hydrophobic interactions not
alleviated by membrane deformations at each TM were identified from sol-
vent accessibilities in the MD trajectories. We found strikingly different en-
ergy costs of hydrophobic mismatch at TMs 4,5 between the beta1 and beta2
adrenergic receptors. In contrast, both kappa and delta opioid receptors ex-
hibited a similar pattern of (small) energy cost around the protein with
slightly more pronounced residual mismatch at TM4. These distinct patterns
of energy differences indicate how small sequence differences in otherwise
homologous GPCRs can affect the mechanisms driving their organization
in the cell membrane.
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We have developed a thermodynamic model that describes the full agonist ac-
tivation of the b1 and b2 adrenergic receptors. The activation mechanism of
Rhodopsin is well understood, for other class A GPCRs the process is not as
well resolved. Rhodopsin combines conformational change with proton uptake
by two internal proton switches to achieve a stable active conformation. There
is evidence to suggest that the b1 and b2 adrenergic receptors use a similar pro-
cess. It has been demonstrated that the b2 adrenergic receptor activity increases
at acidic pH, the result of Asp134 protonation. Molecular dynamics simulations
revealed that deprotonation of Asp79 results in disruption of the ionic lock. Our
hypothesis is that a proton transfer from Asp79 to an unknown proton acceptor
facilitates the transition from inactive to the intermediate state in our model.
This is followed by a conformational change that results in the protonation
of Asp134, a transition that stabilizes active state. We tested our hypothesis
by performing free energy difference (DDG) calculations from a set of Molec-
ular Dynamics simulations of the b1 and b2 receptors with these Aspartic acid
residues occupying different ionization states. These calculations test whether
transitions in ionization states of these residues provide favorable energy for
activation.
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The glucagon-like peptide-1 (GLP-1) receptor is an important target for ago-
nist drugs that may be useful in the treatment of type 2 diabetes mellitus. This
receptor is a member of class B GPCRs, a group believed to associate with
themselves and with each other to form oligomeric complexes. However,
the way such complexes might affect the action of these drugs is not known.
In the current work, we have studied the ability of GLP-1 receptors to oligo-
merize and have explored the influence of receptor oligomerization on the ef-
fects of both peptide and small molecule agonists that activate this receptor.
Bioluminescence resonance energy transfer and bimolecular complementation
were used to demonstrate that GLP-1 receptors constitutively form homo-
dimers that were unaffected by occupation with any of these agonists. The
lipid-exposed face of transmembrane segment 4 (TM4) was the critical deter-
minant for complex formation, based on observations that competition with
TM4 peptide could disrupt such receptor complexes and that TM4 mutants
could interfere with the formation of these complexes. The affinities for bind-
ing and the potencies for agonist stimulation were lower for the monomeric
state than for the dimeric state of this receptor. Treatment with GppNHp
shifted the affinity of the dimeric receptor state of the receptor, but not its
monomeric state. Negative cooperativity of natural ligand binding was ob-
served only for the dimeric receptor state as well. We also characterized
the influence of the dimeric state on signaling activities of various orthosteric
and allosteric GLP-1 receptor agonists. The work provides novel insight into
the importance of receptor oligomerization on the function of Family B
GPCRs.
